BIRC6 and prostate carcinoma: In view of the pro-survival function of BIRC6 in prostate cancer cells (Figs 3B, 4A, B) and in other systems [21], [23]–[26], elevations in the expression of BIRC6 are expected to provide a cytoprotective advantage to prostate cancer cells and promote prostate cancer development and progression.